For Medical Providers

Peripheral T-cell leukemias and lymphomas are a rare group of lymphoid malignancies with poor outcomes when treated with contemporary regimens. There are no established standard-of-care strategies for the majority of the PTCL subtypes. Clinical trials are preferred for both newly diagnosed and relapsed/refractory PTCL patients. In this section you will find useful references for commonly used chemotherapy protocols, links to national guidelines, and a comprehensive list of available clinical trials. This information is regularly updated, please revisit this section for new additions and edits.